Bench to Bedside in the Diagnosis and Treatment of Lupus Nephritis

Moderator(s)

• LS

  Lisa Sammaritano, MD

  Hospital for Special Surgery
  New York, New York, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose
• MC

  May Choi, MD, FRCPC, MPH

  University of Calgary
  Calgary, Alberta, Canada

  Disclosure(s): AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Celltrion: Consultant (Terminated, January 1, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); GlaxoSmithKlein(GSK): Consultant (Terminated, January 2, 2023); Mallickrodt Pharmaceuticals: Consultant (Terminated, January 2, 2023); MitogenDx: Consultant (Ongoing); Organon: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); Werfen: Consultant (Ongoing)

Session Coordinator(s)

• AA

  Anca Askanase, MD, MPH

  Director
  Columbia University Medical Center
  New York, New York, United States

  Disclosure(s): Alumis: Advisor or Review Panel Member (Ongoing); Amgen: Advisor or Review Panel Member (Terminated, August 15, 2024); AstraZeneca: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bristol-Myers Squibb(BMS): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Cabaletta: Grant/Research Support (Ongoing); Genentech: Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Idorsia: Grant/Research Support (Ongoing); Janssen: Advisor or Review Panel Member (Ongoing); NKARTA: Grant/Research Support (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); Sanofi: Grant/Research Support (Ongoing); UCB: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing)

Lupus Nephritis

Presentations:

• 1:00 PM – 1:30 PM Central Time

  Applying Learnings from the AMP Program into the Clinic
  

  Speaker: Andrea Fava, MD – Johns Hopkins University
• 1:30 PM – 2:00 PM Central Time

  Applying the Guideline to the Treatment of Refractory LN
  

  Speaker: Maria Dall'Era, MD – UCSF
• 2:00 PM – 2:30 PM Central Time

  Applying the Guideline to the Treatment of LN for Newly Available Treatments
  

  Speaker: Anca Askanase, MD, MPH – Columbia University Medical Center